Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: Are primary care physicians ready?

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 4, 2008, Pages 635-639

  Shields, A E ^a,b   Lerman, C ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; COCAINE DEPENDENCE; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; OPIATE ADDICTION; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; TOBACCO DEPENDENCE;

CLINICAL COMPETENCE; GENETIC PREDISPOSITION TO DISEASE; GENETIC RESEARCH; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICALLY UNDERSERVED AREA; PHARMACOGENETICS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; SUBSTANCE-RELATED DISORDERS;

EID: 40949124834     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.4     Document Type: Review

References (27)

1. Munafo, M., Shields, A.E., Berrettini, W., Patterson, F. & Lerman, C. Pharmacogenetics and nicotine addiction treatment. Pharmacogenetics 6, 211-223 (2005).
2. Enoch, M.A. Pharmacogenomics of alcohol response and addiction. Am. J. Pharmacogenomics 3, 217-232 (2003).
3. Kreek, M.J., Bart, G., Lilly, C., LaForge, K.S. & Nielsen, D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 57, 1-26 (2005).
4. Shields, A.E., Lerman, C. & Sullivan, P. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. Nicotine Tob. Res. 6, 675-688 (2004).
5. Burke, W. & Emery, J. Genetics education for primary-care providers. Nat. Rev. Genet. 3, 561-566 (2002).
6. Shields, A.E., Blumenthal, D., Weiss, K., Comstock, C., Currivan, D. & Lerman, C. Barriers to translating emerging genetic research on smoking into clinical practice: perspectives of primary care physicians. J. Gen. Intern. Med. 20, 131-138 (2005).
7. Suchard, M.A., Yudkin, P. & Sinsheimer, J.S. Are general practitioners willing and able to provide genetic services for common diseases? J. Genet. Couns. 8, 301-311 (1999).
8. Rutter, J.L. Symbiotic relationship of pharmacogenetics and drugs of abuse. AAPS J. 8, E174-E184 (2006).
9. Uhl, G.R., Liu, Q.R., Drgon, T., Johnson, C., Walther, D., Rose, J.E. et al. Molecular genetics of successful smoking cessation: convergent genome-wide association results. Arch. Gen. Psychiatry (in press).
10. Shields, A.E., Fortun, M., Hammonds, E., King, P.A., Lerman, C., Rapp, R. et al. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. Am. Psychol. 60, 77-103 (2005).
11. Shields, A.E., Levy, D.E., Blumenthal, D., Currivan, D., McGinn-Shapiro, M., Weiss, K.B. et al. Anticipating complexity: primary care physicians willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine Tob. Res. (in press).
12. Levy, D.E., Youatt, E.J. & Shields, A.E. Primary care physicians' concerns about offering a genetic test to tailor smoking cessation treatment. Genet. Med. 9, 842-849 (2007).
13. Tate, S.K. & Goldstein, D.B. Will tomorrow's medicines work for everyone? Nat. Genet. 36, S34-S42 (2004).
14. Cooper, R.S., Kaufman, J.S. & Ward, R. Race and genomics. N. Engl. J. Med. 348, 1166-1170 (2003).
15. Shriver, M.D., Parra, E.J., Dios, S., Bonilla, C., Norton, H., Jovel, C. et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum. Genet. 112, 387-399 (2003).
16. Need, A.C., Motulsky, A.G. & Goldstein, D.B. Priorities and standards in pharmacogenetic research. Nat. Genet. 37, 671-681 (2005).
17. Burt, C., Hing, E. & Woodwell, D. Electronic Medical Record Use by Office-based Physicians: United States, 2005 (National Center for Health Statistics, Hyattsville, 2005).
18. Blumenthal, D., Causino, N., Chang, Y.C., Culpepper, L., Marder, W., Saglam, D. et al. The duration of ambulatory visits to physicians. J. Fam. Pract. 48, 264-271 (1999).
19. Freedman, A., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K. et al. US physicians' attitudes toward genetic testing for cancer susceptibility. Am. J. Med. Genet. A 120, 63-71 (2003).
20. Wideroff, L., Freedman, A.N., Olson, L., Klabunde, C., Davis, W., Srinath, K.P. et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol. Biomarkers Prev. 12, 295-303 (2003).
21. Bach, P.B., Pham, H.H., Schrag, D., Tate, R.C. & Hargraves, J.L. Primary care physicians who treat blacks and whites. N. Engl. J. Med. 351, 575-584 (2004).
22. Collins, F.S. Preparing health professionals for the genetic revolution. JAMA 278, 1285-1286 (1997).
23. Hall, M.J. & Olopade, O.I. Confronting genetic testing disparities: knowledge is power. JAMA 293, 1783-1785 (2005).
24. Groeneveld, P.W., Laufer, S.B. & Garber, A.M. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries 1989-2000. Med. Care 43, 320-329 (2005).
25. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (The National Academies Press, Washington, DC, 2002).
26. Powers, M. & Faden, R. Social Justice: The Moral Foundations of Public Health and Health Policy (Oxford Univ. Press, New York, 2006).
27. Collins, F.S., Green, E.D., Guttmacher, A.E. & Guyer, M.S. A vision for the future of genomics research. Nature 422, 835-847 (2003).